7,376.86

+23.13

+0.31%

51,285.73

-237.37

-0.46%

24,579.42

+264.42

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,776.17

+83.95

+0.11%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

OTC Markets OTCPK USD

BioVaxys Technology Corp. (BVAXF)

0.0900 0.0000 (0.00%)

At close: November 6 at 4:00:00 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

TMX Newsfile 1mo ago

BIOV.CN

BVAXF
0.00%
5LB.F
BioVaxys Reports Positive Phase 2 Data for Maveropepimut (MVP-S) + Pembrolizumab and Low-Dose Cyclophosphamide in Metastatic Bladder Cancer

NewMediaWire 9mo ago

BVAXF
0.00%
BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer

TMX Newsfile 9mo ago

BVAXF
0.00%
BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer

TMX Newsfile 10mo ago

BVAXF
0.00%

Performance Overview

Return	BVAXF	S&P/TSX Composite index (^GSPTSE)
YTD	-46.22%	+12.31%
1-Year	-53.85%	+18.89%
3-Year	-37.72%	+80.53%

Mobilize your Website

View Site in Mobile | Classic

Share by: